(function(){var loadHandler=window['sl_{B169E353-1691-4AFC-B51D-F07AF60FC333}'];loadHandler&&loadHandler(12, '<div id="spr0_587869f5"><div id="spr1_587869f5" class="kern slide"><img id="img2_587869f5" src="data/img1.png" width="720px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_587869f5" class="kern slide"><div id="spr3_587869f5" style="left:0.002px;top:0.001px;"><img id="img0_587869f5" src="data/img2.png" width="720" height="540" alt="" style="left:-0.001px;top:-0px;"/></div><img id="img1_587869f5" src="data/img3.png" width="721.48" height="100.8" alt="" style="left:-1.482px;top:200.984px;"/><div id="spr4_587869f5" style="left:1.482px;top:223.955px;"><div style="width:0px;"><span id="txt0_587869f5" data-width="511.765625" style="left:104.125px;top:5.086px;">Do PCSK9 Inhibitors Reduce CV Events?</span></div></div></div></div>');})();